Results 261 to 270 of about 41,661 (291)
Some of the next articles are maybe not open access.

Androgen Deprivation Therapy

2023
Richard J. Wassersug   +2 more
openaire   +2 more sources

Androgen deprivation therapy: past, present and future

BJU International, 2012
Since Huggins and Hodges demonstrated the responsiveness of prostate cancer to androgen deprivation therapy (ADT), androgen‐suppressing strategies have formed the cornerstone of management of advanced prostate cancer. Approaches to ADT have included orchidectomy, oestrogens, luteinizing hormone‐releasing hormone (LHRH) agonists, anti‐androgens and more
F, Schröder   +4 more
openaire   +2 more sources

Androgen Deprivation Therapy Cardiotoxicity

2021
The patient is a 63-year-old male, case of metastatic castrate-sensitive prostate cancer on goserelin injections every 3 month. Given his initial Gleason1 grade of 8, as well as doubling Prostate-specific antigen, (PSA) in 7 months since starting treatment, he was started on androgen receptor inhibitor, apalutamide.
openaire   +1 more source

Androgen Deprivation Therapy

Reviews in urology, 2011
Paul, Hoffman, Bob, Djavan
openaire   +3 more sources

Pitfalls of Androgen Deprivation Therapy

2012
Androgen deprivation therapy (ADT) is a widely used method of treatment for men with prostate cancer. In men with metastatic disease, primary ADT improves quality of life and extends overall survival. ADT improves both progression free and overall survival in men with intermediate and high risk early stage disease.
Alicia K. Morgans, Matthew R. Smith
openaire   +1 more source

Regarding Sequencing of Androgen-Deprivation Therapy

Journal of Clinical Oncology, 2023
Anthony Abner, Frank Vicini
openaire   +2 more sources

Intermittent Versus Continuous Androgen Deprivation Therapy

Journal of the National Comprehensive Cancer Network, 2014
Androgen deprivation therapy (ADT) has been the standard of care for metastatic prostate cancer for decades; however, the choice of continuous or intermittent administration is a matter of debate. Two large phase III trials have reported results comparing these 2 forms of ADT administration.
openaire   +2 more sources

Home - About - Disclaimer - Privacy